Soleno Therapeutics to Participate in Upcoming Investor Conferences
Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, announced CEO Anish Bhatnagar will participate in two upcoming investor conferences. The Jefferies Global Healthcare Conference is set for June 5, 2024, at 11:30 AM ET, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 4:00 PM ET. Live audio webcasts and replays will be available on the company's website.
- Soleno's participation in high-profile investor conferences may attract new investors and boost its visibility.
- The company is engaging with the investment community, which can provide strategic insights and potential funding opportunities.
- No new clinical data or financial updates were provided in this announcement.
- Participation in conferences does not guarantee positive stock performance or direct financial benefits.
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in the following upcoming investor conferences:
| Event: | Jefferies Global Healthcare Conference |
| Day: | Wednesday, June 5, 2024 |
| Time: | 11:30 AM Eastern Time |
| Event: | Goldman Sachs 45th Annual Global Healthcare Conference |
| Day: | Tuesday, June 11, 2024 |
| Time: | 4:00 PM ET |
A live audio webcast and replay of the events will be available in the Investors section on the Company’s website at www.soleno.life.
About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of PWS, recently completed its Phase 3 development program to support a planned NDA submission. For more information, please visit www.soleno.life.
Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578
FAQ
What is the significance of Soleno Therapeutics (SLNO) participating in the Jefferies Global Healthcare Conference?
When will Soleno Therapeutics (SLNO) present at the Goldman Sachs 45th Annual Global Healthcare Conference?
Will there be a live webcast for Soleno Therapeutics' (SLNO) investor conference presentations?
Who is presenting from Soleno Therapeutics (SLNO) at the upcoming investor conferences?
